Self-Management of Heparin Therapy - Drug Use Problems and Compliance With Self-Injected Low Molecular Weight Heparin in Ambulatory Care.

Trial Profile

Self-Management of Heparin Therapy - Drug Use Problems and Compliance With Self-Injected Low Molecular Weight Heparin in Ambulatory Care.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Dalteparin sodium (Primary) ; Low molecular weight heparins
  • Indications Thromboembolism
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Aug 2009 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 19 Jun 2009 Planned end date changed from 1 Jun 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top